Trials / Not Yet Recruiting
Not Yet RecruitingNCT06647914
Predicting Disease Progression in Atrial Fibrillation: A Multiparametric Approach for Prognostic Marker Identification and Personalized Patient Management
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 322 (estimated)
- Sponsor
- IRCCS Policlinico S. Donato · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This project leverages artificial intelligence (AI) to decipher Atrial Fibrillation (AF) progression and optimize treatment strategies. By recruiting a diverse cohort of 322 AF patients, we will gather a robust multiparametric dataset including clinical, genetic, electrocardiographic, and echocardiographic data. Harnessing AI, we will extract and correlate hidden components within ECG-obtained P-wave data and echocardiographic studies with atrial fibrosis, culminating in an atrial fibrosis score (AFS). The AFS will non-invasively predict fibrosis extent and AF clinical progression, including metrics like rehospitalization, cardiac morbidity, and mortality. Ultimately, this endeavor aims to improve AF patient management, significantly reducing healthcare costs, and enhancing patient quality of life.
Conditions
Timeline
- Start date
- 2025-09-03
- Primary completion
- 2026-03-01
- Completion
- 2026-08-31
- First posted
- 2024-10-18
- Last updated
- 2024-10-18
Source: ClinicalTrials.gov record NCT06647914. Inclusion in this directory is not an endorsement.